Latest News
Resonant Therapeutics Forges Collaboration with Janssen
6 December 2019 - - US-based Resonant Therapeutics, Inc. has entered into an agreement with US-based healthcare company Johnson and Johnson's (NYSE: JNJ) Janssen Research and Development, LLC business with the aim to discover and validate novel ...
PPD Expands Special Patient Capabilities in Early Development Research
6 December 2019 - - US-based contract research organisation PPD, Inc. has expanded its early development research services by adding significant neuroscience and ethno-bridging expertise, broadening its capabilities to provide increased acc...
Merrimack Receives USD 5m Milestone Payment from Ipsen
6 December 2019 - - US-based drugmaker Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) has received a USD 5m milestone payment from French drugmaker Ipsen (OTC: IPSEF), triggered by Ipsen's decision to progress the ongoing multi-part clinical tri...
Celmatix Expands Strategic Partnership with Evotec in Women's Health
6 December 2019 - - US-based precision health company Celmatix Inc has expanded its strategic alliance with drug discovery and development firm Evotec, the company said.

This news follows an October announcement that the two category lea...
Veracyte Acquires Exclusive License to NanoString Diagnostics Platform
6 December 2019 - - US-based genomic diagnostics company Veracyte (NASDAQ: VCYT) has executed a definitive agreement with NanoString for the exclusive global license to the nCounter platform for diagnostic use, the company said.